568 related articles for article (PubMed ID: 17454012)
21. Perceived barriers to hepatitis C therapy for patients receiving opioid agonist treatment.
Zickmund SL; Campbell SA; Tirado CF; Zook CL; Weinrieb RM
J Addict Med; 2012 Sep; 6(3):233-9. PubMed ID: 22790464
[TBL] [Abstract][Full Text] [Related]
22. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
23. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
[TBL] [Abstract][Full Text] [Related]
24. A review of patients on methadone maintenance.
Taj R; Keenan E; O'Connor JJ
Ir Med J; 1995; 88(6):218-9. PubMed ID: 8575924
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of brief alcohol interventions for general practice patients with problematic drinking behavior and comorbid anxiety or depressive disorders.
Grothues JM; Bischof G; Reinhardt S; Meyer C; John U; Rumpf HJ
Drug Alcohol Depend; 2008 Apr; 94(1-3):214-20. PubMed ID: 18207336
[TBL] [Abstract][Full Text] [Related]
26. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B
Am J Drug Alcohol Abuse; 2007; 33(5):665-74. PubMed ID: 17891659
[TBL] [Abstract][Full Text] [Related]
27. Every third patient in primary care suffers from depression, anxiety or alcohol problems.
Nordström A; Bodlund O
Nord J Psychiatry; 2008; 62(3):250-5. PubMed ID: 18609025
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C treatment eligibility and comorbid medical illness in methadone maintenance (MMT) and non-MMT patients: a case-control study.
Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R; Levine RA
J Addict Dis; 2010 Jul; 29(3):359-69. PubMed ID: 20635285
[TBL] [Abstract][Full Text] [Related]
29. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
[TBL] [Abstract][Full Text] [Related]
30. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study.
Clausen T; Anchersen K; Waal H
Drug Alcohol Depend; 2008 Apr; 94(1-3):151-7. PubMed ID: 18155364
[TBL] [Abstract][Full Text] [Related]
31. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
Winstock AR; Lea T; Sheridan J
Drug Alcohol Rev; 2008 Jul; 27(4):393-7. PubMed ID: 18584389
[TBL] [Abstract][Full Text] [Related]
32. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
[TBL] [Abstract][Full Text] [Related]
33. Short-term recovery from alcohol abuse or dependence: any evidence of a relationship with treatment use in a general population sample?
Cunningham JA
Alcohol Alcohol; 2005; 40(5):419-21. PubMed ID: 15939710
[TBL] [Abstract][Full Text] [Related]
34. Substance use and treatment seeking in young offenders on community orders.
Lennings CJ; Kenny DT; Nelson P
J Subst Abuse Treat; 2006 Dec; 31(4):425-32. PubMed ID: 17084797
[TBL] [Abstract][Full Text] [Related]
35. Intention to change drinking behaviour in general practice patients with problematic drinking and comorbid depression or anxiety.
Grothues J; Bischof G; Reinhardt S; Hapke U; Meyer C; John U; Rumpf HJ
Alcohol Alcohol; 2005; 40(5):394-400. PubMed ID: 15996967
[TBL] [Abstract][Full Text] [Related]
36. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
Bramness JG; Kornør H
Drug Alcohol Depend; 2007 Oct; 90(2-3):203-9. PubMed ID: 17478058
[TBL] [Abstract][Full Text] [Related]
37. Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study.
Belfiori B; Chiodera A; Ciliegi P; Tosti A; Baldelli F; Stagni G; Francisci D
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):731-2. PubMed ID: 17625449
[No Abstract] [Full Text] [Related]
38. Who seeks treatment for alcohol dependence? Findings from the Australian National Survey of Mental Health and Wellbeing.
Proudfoot H; Teesson M;
Soc Psychiatry Psychiatr Epidemiol; 2002 Oct; 37(10):451-6. PubMed ID: 12242622
[TBL] [Abstract][Full Text] [Related]
39. Alcohol misuse and multiple sclerosis.
Turner AP; Hawkins EJ; Haselkorn JK; Kivlahan DR
Arch Phys Med Rehabil; 2009 May; 90(5):842-8. PubMed ID: 19406306
[TBL] [Abstract][Full Text] [Related]
40. Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population.
Bradley KA; Bush KR; Epler AJ; Dobie DJ; Davis TM; Sporleder JL; Maynard C; Burman ML; Kivlahan DR
Arch Intern Med; 2003 Apr; 163(7):821-9. PubMed ID: 12695273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
